ArticleBrain sciences2022

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report.

Yun Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.